pentasa slow release granules 4 g.
ferring pharmaceuticals ltd - mesalazine - granules - mesalazine 4000 mg - mesalazine - mild to moderate ulcerative colitis or crohn's disease.
pentasa slow release tablets 1 gram
ferring pharmaceuticals ltd - mesalazine - tablets slow release - mesalazine 1 g - mesalazine - mild to moderate ulcerative colitis. crohn's disease.
ag-metformin tablet
angita pharma inc. - metformin hydrochloride - tablet - 500mg - metformin hydrochloride 500mg - biguanides
ag-metformin tablet
angita pharma inc. - metformin hydrochloride - tablet - 850mg - metformin hydrochloride 850mg - biguanides
rekovelle 12
ferring pharmaceuticals ltd - follitropin delta - solution for injection - follitropin delta 12 mcg / 0.36 ml - follitropin delta - controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (art) such as an in vitro fertilisation (ivf) or intracytoplasmic sperm injection (icsi) cycle. there is no clinical trial experience with rekovelle in the long gnrh agonist protocol
rekovelle 36
ferring pharmaceuticals ltd - follitropin delta - solution for injection - follitropin delta 36 mcg / 1.08 ml - follitropin delta - controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (art) such as an in vitro fertilisation (ivf) or intracytoplasmic sperm injection (icsi) cycle. there is no clinical trial experience with rekovelle in the long gnrh agonist protocol
rekovelle 72
ferring pharmaceuticals ltd - follitropin delta - solution for injection - follitropin delta 72 mcg / 2.16 ml - follitropin delta - controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (art) such as an in vitro fertilisation (ivf) or intracytoplasmic sperm injection (icsi) cycle. there is no clinical trial experience with rekovelle in the long gnrh agonist protocol
firmagon 120 mg
ferring pharmaceuticals ltd - degarelix as acetate - powder and solvent for solution for infusion - degarelix as acetate 120 mg - degarelix - for the treatment of adult male patients with advanced hormone-dependent prostate cancer.
firmagon 120 mg
ferring pharmaceuticals ltd - degarelix as acetate - powder and solvent for solution for injection - degarelix as acetate 120 mg - degarelix - for the treatment of adult male patients with advanced hormone-dependent prostate cancer.
firmagon 80 mg
ferring pharmaceuticals ltd - degarelix as acetate - powder and solvent for solution for injection - degarelix as acetate 80 mg - degarelix - for the treatment of adult male patients with advanced hormone-dependent prostate cancer.